eWellness Announces the Developing New Rheumatoid Arthritis Treatment Platform RA360
Retrieved on:
Tuesday, November 12, 2019
Culver City, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation (EWLL) a provider of the state of the art PHZIO platform for the physicaltherapy (PT) and telehealth markets,announced today that it is developing a new Rheumatoid Arthritis Treatment Platform called RA360.
Key Points:
- Culver City, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation (EWLL) a provider of the state of the art PHZIO platform for the physicaltherapy (PT) and telehealth markets,announced today that it is developing a new Rheumatoid Arthritis Treatment Platform called RA360.
- Rheumatoid Arthritis and related autoimmune disorders are the leading cause of illness and disability in the US.
- Rheumatoid Arthritis (RA): Those with Rheumatoid arthritis will need to go on disability or stop work entirely within 2 years of onset.
- Our innovative RA360 solution is anticipated to support employees to reduce or maintain their current level of theraputic drug use.